Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase TRIM21 (TRIM21) is a member of the TRIM (tripartite motif) protein family, characterized by the presence of a RING domain (responsible for its E3 ubiquitin ligase activity), B-box motifs, a coiled-coil region, and a C-terminal PRY/SPRY domain. TRIM21 is a distinctive cytosolic Fc receptor that binds to the Fc region of antibodies and plays a central role in *intracellular immunity*: when antibody-coated pathogens are internalized into the cytosol, TRIM21 recognizes them and triggers their rapid degradation through the ubiquitin-proteasome system, a process termed antibody-dependent intracellular neutralization. Beyond antiviral defense, TRIM21 functions in the regulation of immune signaling and is a major autoantigen in several systemic autoimmune diseases, notably Sjögren’s syndrome, systemic lupus erythematosus, and rheumatoid arthritis. The presence of anti-TRIM21 (anti-Ro52) autoantibodies is used diagnostically in these conditions. TRIM21 is being explored as a tool for selective degradation of intracellular proteins (Trim-Away technology) for research and therapeutic purposes[1][2][3][4].
Polyubiquitination leading to proteasomal degradation of antibody-bound targets (antibody-dependent intracellular neutralization[2]); Modulation of innate immune pathways via ubiquitination-dependent signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin-protein ligase TRIM21 (TRIM21).